After three years of R&D, Hyundai Mobis has succeeded in developing M.Brain, a new healthcare technology based on brainwave measurement and applied to the automotive industry for the first time. Among other biosignals, brainwave measurement is known to be one of the most advanced and challenged technologies to work with. M.Brain measures the driver’s condition on a real-time basis by detecting the brainwaves around the ears through earpiece sensors that are worn. The key is the software technology that analyzes and determines the data from the brainwaves. Hyundai Mobis uses machine learning to interpret the brainwave signals.
M.Brain can also be linked with a smartphone app and provide notification that the driver is losing attention. The accident prevention technology also provides alerts for different sensory organs, such as sight (LEDs around the driver’s seat), touch (vibrating seat), hearing (headrest speaker), etc.
Hyundai Mobis plans to apply various bio-healthcare technologies to public transportation with a view to contributing to public safety. M. Brain will be applied and tested in Gyeonggi-do’s public buses first. The application scope of the biotechnology will then be expanded to smart cities and purpose-built vehicle (PBV) later.
The global in-vehicle healthcare market has taken its first steps with heartbeat measurements or eye tracking technologies being introduced. Meanwhile, brainwave-based technology shows infinite potential for development as it is capable of measuring massive amounts of data.
Hyundai Mobis is showing progress in developing autonomous driving healthcare technology using biosignals. At the CES in 2018, the company presented DDREM (Departed Driver Rescue & Exit Maneuver), which works to prevent accidents that occur as a result of drowsy driving. Hyundai Mobis then succeeded in developing the eye tracking DSW (Driver State Warning) system in 2019, and ROA (Rear Occupant Alert) system to detect infants in the backseat using radar last year.